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Abstract
Anxiety and depression are multifactorial disorders that have become prominent health prob-
lems all over the world. Neurotrophic factors have emerged underlying pathogenesis of these
diseases. Although a number of studies indicate that the hippocampus-brain-derived neuro-
trophic factor (BDNF) may be involved in these psychiatric illnesses, little is known about the
molecular mediators of these disorders. In this study we further investigate the role of tissue
plasminogen activator (tPA), a serine protease involved in pro-BDNF cleavage to BDNF, in de-
pression and anxiety-like behaviors in adult mice. To address this issue, we investigated the
effect of hippocampus tPA manipulation, using viral vectors, on anxiety- and depression-
like behaviors, including the marble burying test (MBT), elevated plus maze (EPM), tail sus-
pension test (TST), novelty suppressed feeding (NSF) and forced swim test (FST). Our results
showed that tPA knock-down – using lentiviral vectors expressing specific short hairpin RNAs
(LV-shRNA) – increased the number of buried marbles together with the digging time in the
MBT and decreased the time spent in open the arms of an EPM. In addition, tPA-knock down
in the hippocampus increased immobility in the FST and TST, and increased time to feed in
the NSF test. These effects were reversed when tPA-over-expressing vectors (LV-tPA) were
injected in the hippocampus. We also found that BDNF protein levels were elevated in the
hippocampus of mice receiving tPA-expressing vectors. Together, our results imply that
Abbreviations: BDNF, brain-derived neurotrophic factor; CA, closed Arms; EPM, elevated plus maze; FST, forced swim test; HEK293T, human
embryonic kidney 293T; LV, lentivirus vector; MBT, marble burying test; NSF, novelty suppressed feeding; OA, open Arms; PLC, phospholipase
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1. Introduction
Anxiety and depression affect number of people throughout
the world and are leading cause of disability. In fact the
World Health Organization estimates that 2–3% in general
populations of countries across the world tend to be affected
by severe mental disorders (World Mental Health Survey
2000 data). However, the cellular and molecular basis for
the development of these psychiatric disorders is still largely
unknown. There is a substantial body of evidence suggesting
a strong relation between neurotrophic factors and depression
and anxiety pathogenesis (Li et al., 2008; Matrisciano et al.,
2009; Strohle et al., 2010).
Brain-derived neurotrophic factor (BDNF), a member of
the neurotrophic family known to regulate neuronal plastic-
ity and survival (D'Sa and Duman, 2002; Noble et al., 2011;
Numakawa et al., 2010), may play an important role in the
pathophysiology of depression and anxiety. In fact, it has
been reported that serum BDNF levels of the patients with
psychological job stress or panic disorders were significantly
lower than those in control patients (Kobayashi et al., 2005;
Mitoma et al., 2008). Different studies indicated that bipolar
patients who were exposed to traumatic events have anxiety
comorbidity and lower levels of serumBDNF compared to those
without a history of traumatic events (Kauer-Sant'Anna et al.,
2007). Also baseline serum BDNF levels were significantly
lower in depressed patients compared to controls (Kim et al.,
2007; Lee et al., 2007; Matrisciano et al., 2009). Very recently
Schmidt and Duman have shown that when administered pe-
ripherally, BDNF has an antidepressant and anxiolytic effect
in mice. These effects were associated with an enhanced sur-
vival rate of newborn neurons and increases BDNF-mediated
signaling in the hippocampus (Schmidt and Duman, 2010). Fur-
thermore, BDNF-deficient mice developed aggressiveness and
anxiety as well as hyperactive response to stressors (Lyons et
al., 1999; Rios et al., 2001), which suggest that BDNF is impli-
cated in the regulation of anxiety-related behaviors. In addi-
tion, a variant in the human BDNF gene, which leads to a
valine-to-methionine change in the proBDNF protein, was asso-
ciatedwith lower activity-dependent secretion of BDNF (Enoch
et al., 2008) and has been implicated with increased suscepti-
bility to neuropsychiatric disorders including depression,
anxiety-related dysfunction, and bipolar disorder (Lang et
al., 2005; Minelli et al., 2011; Montag et al., 2010). More im-
portantly, mutation of the PLCγ-docking site downstream of
TrkB affects experimentally induced long-term potentiation
and associative learning in behaving mice (Gruart et al.,
2007). Taken together, all these studies suggest that BDNF is
likely to be an important etiological factor in memory, depres-
sion and anxiety disorders.
BDNF arises from a precursor, proBDNF, which is cleaved
to produce the mature protein through the tissue plasminogen
activator (tPA) pathway, and represents one mechanism that
can regulate the action of BDNF (Sartori et al., 2011; Tsai,
2006). tPA is a serine protease that catalyzes the conversion
of plasminogen to plasmin and plays a role in fibrinolysis
(Zorio et al., 2008). In addition, tPA is expressed by many
types of neurons in the developing and adult brain (for review
see Melchor and Strickland, 2005; Teesalu et al., 2002). tPA is
highly expressed in the adult rodent brain in regions involved
in fear and anxiety (amygdala) (Pawlak et al., 2003; Qian et
al., 1993; Zhou et al., 2010), motor learning (cerebellum)
(Seeds et al., 1999), learning and memory (hippocampus/
amygdala) (Lochner et al., 2006; Pothakos et al., 2010), and
addiction (Bahi and Dreyer, 2008, 2011; Nagai et al., 2008;
Noel et al., 2011).
More importantly, the tPA-plasmin proteolytic pathway
was highly associated to major depressive disorders (MDD)
(for review see Hou et al., 2009). In addition and after
acute restraint stress, tPA activity was up-regulated in the
central and medial amygdala promoting stress-related syn-
aptic plasticity and anxiety-like behavior in mice an effect
that was inhibited by plasminogen activator inhibitor-1
(PAI-1) (Pawlak et al., 2003). The same groups have shown
later that the amygdala corticotropin-releasing factor
(CRF) mediated tPA activity up-regulation through the CRF
type-1 receptors (Matys et al., 2004). These findings suggest
that tPA is involved in the regulation of numerous aspects of
neuronal remodeling and psychiatric disorders.
In the present study we performed a series of experi-
ments to examine the effects of stress on tPA expression
and enzymatic activity in the hippocampus. Using
lentiviral-mediated gene transfer and shRNA expression,
we investigated how tPA manipulation in the hippocampus
may affect anxiety- and depression-like behaviors in adult
mice.
2. Experimental procedures
2.1. Subjects
Male C57BL/6 mice weighing 25–30 g were group-housed (five per
cage) with a 12-h light/dark cycle (lights on at 7 am) and provided
ad libitum access to food and water until the age of 10–14 weeks.
Age- and body weight-matched male mice were used for behavioral
experiments. The experiments were conducted in an isolated be-
havioral testing room in the animal facility to avoid external distrac-
tions. In order to facilitate adaptation to the experimental
environment, mice were housed in the testing room for at least
1 week before the experiments started. All animal care and use
were in accordance with the National Institutes of Health Guide
for the Care and Use of Laboratory Animals. All experimental proce-
dures were approved by the local Research Ethic Committee. All ef-
forts were made to minimize both the suffering and the number of
animals used.
2.2. Drugs
Imipramine chlorhydrate (10 mg/kg, i.p.) and diazepam (1 mg/kg,
i.p.) (Sigma, USA) were dissolved in isotonic saline solution (NaCl

ht
tp
://
do
c.
re
ro
.c
h
0.9%) and the volume administered to each animal was 10 mL/kg
body weight. Drugs were injected 30 min before testing the mice.
2.3. Construction and production of lentiviral vectors
These vectors were prepared as described previously (Bahi and
Dreyer, 2008, 2011; Bahi et al., 2008b). Briefly, for tPA-expressing
lentiviral vectors (LV-tPA), tPA was amplified from total brain
cDNA using specific primers and ligated into pTK431. For tPA-
specific shRNA expressing lentiviral vectors (LV-shRNA), using PCR
amplification shRNA oligos were added to the mouse U6 promoter
using pSilencer 1.0-U6 (Ambion, UK) as a template and the PCR
product was digested with Bam HI and Xho I and cloned into similar
sites in pTK431. After cloning and sequencing, all plasmids were
CsCl2-purified and lentiviruses were produced by the transient calci-
um phosphate co-transfection of human embryonic kidney 293T
(HEK293T) cells with pTK vectors together with pMDG-VSV-G and
pΔNRF as described previously (Bahi et al., 2004a, 2004b, 2005a,
2005b, 2006, 2008a, 2008b, 2008c; Bahi and Dreyer, 2008, 2011;
Ortiz et al., 2010). The control mice were injected with LV-Mock,
representing the empty cloning vector.
2.4. Stereotaxic microinjection of lentiviral vectors
Stereotaxic injections were performed as described previously (Bahi
and Dreyer, 2011; Bahi et al., 2009). Mice were anesthetized with
ketamine/xylazine (100 mg/kg, 10 mg/kg, i.p.) and placed in a ste-
reotaxic apparatus. Lentiviral vectors were stereotaxically injected
bilaterally into the hippocampus using following coordinates
(Franklin and Paxinos, 1996): +2.92 mm antero-posterior, ±1.4 mm
lateral from the bregma, and 2.0 mm ventral from the skull (striatum
coordinates: AP +0.62 mm, Lateral ±2.0 mm and DV 3.0 mm). Viruses
were infused at a rate of 0.2 μL/min for 5 min (final volume 1 μL/site).
Following recovery from the operation, mice were used for behavioral
experiments as depicted in Table 1.
2.5. Measurement of tPA and uPA activities and BDNF
protein content
To test tPA (and uPA) enzymatic activities, brains were removed
after rapid decapitation 60 min following 6 min forced swim stress.
The tissue was punched from 2-mm sections with an 18-gauge syringe
and placed immediately in lysis buffer. Fifty micrograms of protein
from each sample were incubated with a specific substrate as de-
scribed previously (Bahi and Dreyer, 2011; Parolini et al., 1996). Reac-
tions were stopped and colorimetric intensity was measured in a
micro-plate spectrophotometer. BDNF protein content was measured
using ELISA BDNF Emax immunoassay system (Promega, USA). The pro-
tein concentration in each sample was measured using a BCA protein
assay kit (Bio-Rad, Switzerland).
2.6. Behavioral studies
2.6.1. Locomotor activity
Mice were habituated to the testing room for 1 h before testing. Lo-
comotor activity was recorded by individually placing the mice into
activity chambers and monitored using EthoVision tracking system
(Noldus, Netherlands) (Bahi and Dreyer, 2011). Activity was recorded
for 90 min and measures were collected in 5 min bins. Data were
expressed as distance traveled (cm).
2.6.2. Marble burying test (MBT)
Before testing mice were habituated to the testing room for 1 h.
Mice were individually placed in Plexiglace cages with 6 cm of fine
sawdust, for a 45-min habituation period. Subsequently, animals
were briefly removed and 20 marbles (1 cm diameter) were placed
in each cage, on top of the sawdust. Mice were then returned to
the cages, and their behavior was recorded for the following
30 min. Measures included the number of buried marbles (when at
least two-thirds of its surface area was covered in sawdust), and
the total duration of digging bouts as measured by time spent burying
marbles (Abe et al., 1998; Njung'e and Handley, 1991; Popova et al.,
2011; Umathe et al., 2011; Uz et al., 2002).
2.6.3. Elevated plus maze test (EPM)
The EPM test is an anxiety paradigm based on the mice's natural
aversion to a novel environment represented by the open and ele-
vated spaces (Bahi et al., 2009). The elevated plus maze apparatus
is a plus (+) shaped structure constructed from Plexiglas, elevated
40 cm above the ground, with two open arms (40 cm×6 cm×0.2 cm)
and two enclosed arms (40 cm×6 cm×17 cm) separated by a central
platform (6 cm×6 cm). One hour before testing, mice were habituated
to the testing room. Mice were then placed individually into the center
of themaze facing an open arm and allowed to explore themaze freely
for a 5 min testing period. The maze was cleaned between runs with a
wet paper towel. The traditional elevated plus maze measures time
spent in open and closed arms and the number of arm entries that
were collected.
2.6.4. Novelty suppressed feeding test (NSF)
Twenty-four hours before testing, food was removed from the cage.
At the day of testing, mice were transferred to the testing room and
after 1-hour habituation period, they were placed in a clear plastic
enclosure (40 cm x 40 cm x 20 cm). The floor was covered with 2 cm
of bedding. A small pre weighed food pellet chow was placed in the
center of the arena on a piece of white circular filter paper. At the
start of the experiment, each mouse was placed in the corner of the
testing arena, and the time to the first feeding event was recorded
during 10 min. The subject was then placed alone for 5 min in its
home cage with the pre weighed piece of food chow. At the end of
the 5-min period, the amount of food consumed was also measured.
For this experiment latency to begin chewing food was measured as
well as amount of food consumed (Guilloux et al., 2011; Liu et al.,
2011; Olivier et al., 2008).
2.6.5. Tail suspension test (TST)
The procedure is similar to the forced swim test in that it measures
“behavioral despair” in mice (i.e. mice stop struggling in the face of
an inescapable stressor). After 1-hour habituation to testing room,
each mouse was suspended individually by its tail from a metal
rod. The rod was fixed 50 cm above the surface of a table covered
with soft cloth in a sound-attenuated room. The tip of the mouse's
tail was fixed on the rod using adhesive Scotch tape. The duration of
the test was 6 min and the immobility time (s) of the tail-suspended
mice was measured as previously described (Bahi et al., 2009).
2.6.6. Forced swim test (FST)
The procedure is based on that described previously (Bahi et al.,
2009). Mice were habituated to the testing room for 2 h before the
experiment. The forced swim test was conducted by individually
placing the mice into cylindrical plastic transparent containers
(height, 25 cm; diameter, 18 cm) containing 15 cm of water at
~25 °C. Immobility was analyzed during 6 min andmicewere removed
from the container and left to dry in a heated enclosure before they
were returned to their home cages. Test-swims were subsequently
assessed for immobility time (s). Immobility behavior was described
as when the animal remains floating passively in the water without
any vertical or horizontal movements.
Table 1 Time line of the behavioral experiments.
Days 1 14 15 17 19 21 23
Test Surgery Locomotion MBT EPM TST NSF FST
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Both TST and FST experimental procedures are based on the fact
that when mice are forced into an aversive situation from which
they cannot escape they will become immobile. Antidepressants,
like imipramine, reduce the immobility time in these tests
(Gadotti et al., 2012; Liang et al., 2008; Sales et al., 2011; Shieh
et al., 2008) indicating that these methods can be used to test for
depression-related behavior in mice.
2.7. Statistical analysis
For statistical comparisons, the software package SPSS (version
19.0) was used. Mean values and SEM were calculated for each
group and all experiments were subjected to a between-subjects
design with virus as the independent variable. Dependent variables
for each behavioral model were analyzed using a one-way ANOVA.
For the experiment testing the effect of imipramine in TST or Diazepam
in EPM, the datawere analyzed using a two-way ANOVAwhere themain
factors under considerationwere virus (Mock, LV-shRNA or LV-tPAmice)
and treatment (vehicle or imipramine/Diazepam). For the locomotor
activity study, repeated measures were collected from a single animal
at different time points and data were analyzed using a one-way re-
peated measure ANOVA. pb0.05 denotes a statistically significant
difference.
3. Results
3.1. Stress decreases tPA activity in the hippocampus
In this experiment we examined tPA and uPA activities in the
hippocampus protein extracts after a forced swim stress using
an enzymatic assay. The striatum was used as a control region.
Mice were stressed for 6 min and killed 60 min later. As shown
in Fig. 1A, stress decreased tPA activity [F(3,18)=3.647;
pb0.05, n=5–6]. Post-hoc analysis revealed that forced-swim
mice displayed lower tPA enzymatic activity in the hippocampus
compared to naïve littermates (pb0.05). In contrast, when tPA
enzymatic activity was tested in the striatum there was no dif-
ference between naive and stressed mice (pN0.05). In the same
experiment we decided to test the enzymatic activity of the
urokinase plasminogen activator (uPA), another neuronal serine
protease involved in the plasminogen-plasmin degradation path-
way, but not able to cleave proBDNF to BDNF. Results showed that
uPA enzymatic activity was not affected upon forced swimming [F
(3,18)=0.117; pN0.05] (Fig. 1B). These results suggest that acute
stress induces a down-regulation of tPA activity in the hippocampus
but not in the striatum.
Based on these findings we decided to manipulate tPA expres-
sion in the hippocampus and in the striatum to determine whether
tPA knock down, using shRNA-expressing lentiviral vectors, or
over-expression can affect depression- and anxiety-like behaviors
in adult mice. The injection sites are summarized in (Fig. 1C, D).
3.2. Locomotor activity
Spontaneous locomotor activity study revealed no significant vi-
rus effect. Total distance moved during the 90 min testing was
similar in all groups [F(2,67)=0.013; pN0.05, n=9–11]
(Fig. 2A). Also there was no effect of the brain region tested
[F(1,67)=0.071; pN0.05]. Consequently no virus×region inter-
action was detected [F(2,67)=0.482; pN0.05]. There were no
differences in distance moved, when the data were analyzed
at different time points or intervals using a one-way repeated
measures analysis (e.g. 0–30 min, 31–60 min, 61–90 min)
(Fig. 2B). There was a significant effect of time [F(2,66)
=13.358; pb0.05], but no significant effect of virus [F(2,66)
=0.224; pN0.05] or time×virus interaction [F(4,66)=0.429;
pN0.05], suggesting a normal habituation profile in locomotion
when tested in a novel environment (Fig. 2B).
3.3. Elevated anxiety-like behaviors in tPA-deficient
mice
As depicted in Fig. 3A tPA manipulation using stereotaxic injec-
tion of viral vectors had a significant effect on marble-burying
Figure 1 tPA and uPA enzymatic activities in the hippocam-
pus. A) tPA and B) uPA enzymatic activities in mice hippocampal
and striatal protein extracts following force swim test. *pb0.05
compared to “Naive”. In both panels, data represent the Mean
±SEM. n=5–6 mice per group. Schematic representation of the
sites of lentiviral vector injection into the C) hippocampus and
D) dorsal striatum.
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indicated by ANOVA analysis [F(2,30)=10.623; pb0.01,
n=9–11]. LV-tPA decreased the number of marbles buried but
LV-shRNA increased it (Fig. 3A). This effect was absent when vi-
ral vectors were injected into the striatum [F(2,31)=0.103;
pN0.05]. Also, the time spent digging was similarly affected by
tPA manipulation in the hippocampus [F(2,30)=11.694;
pb0.01] but not in the striatum [F(2,31)=0.945; pN0.05]
(Fig. 3B).
Next, we examined the differences in behavior of Mock,
LV-shRNA, and LV-tPA-injected mice in the EPM, which is widely
used in laboratories to evaluate anxiety-like behaviors in mice
(Bahi et al., 2009; Lister, 1987; Moser, 1989; Pellow et al.,
1985). This technique is based on the innate aversion of rodents
to open areas and on the spontaneous exploratory behavior of
the animals. It is thought that the time spent in the open arms
of the maze is inversely correlated to their level of anxiety-
related proneness. As shown in Fig. 3C, LV-shRNA mice spent
less time in open arms as compared to LV-tPA or Mock-injected
mice [F(2,30)=15.811; pb0.001, n=9–11]. In contrast, when vi-
ral vectors were injected into the striatum, tPA knock down or
overexpression did not affect the time spent in open arms [F
(2,31)=0.171; p=0.843]. Also, as shown in Fig. 3D the number
of entries in open arms was affected when tPA expression was
manipulated into the hippocampus [F(2,30)=28.742;
pb0.001]. Post hoc analysis showed that LV-shRNA-injected
mice displayed less open arm entries compared to Mock control
animals (p=0.002) but tPA over expressing mice displayed
greater open arms entries (p=0.001). Also, tPA manipulation
in the striatum did not affect the open arm entries in this test
[F(2,31)=0.134; pN0.05]. The overall activity was estimated
by the number of entries performed into the closed arms during
a 5-min observation period. Interestingly, as depicted in Fig. 3E
this parameter was not affected by lentiviral injection in the
hippocampus [F(2,30)=0.278; pN0.05] neither in the striatum
[F(2,31)=0.052; pN0.05] indicating no change in overall ambu-
latory behavior.
As the results of the elevated plus maze experiments sug-
gested that tPA knockdown leads to an increase in anxiety-like
behaviors, we decided to confirm these observations using an
anxiolytic drug primarily used to reverse anxiogenic behaviors
(Corbett et al., 1991; Dunn et al., 1989; Golda and Petr, 1989;
Karakas et al., 2011; Nomikos and Spyraki, 1988). As shown in
Fig. 3F, treatment of mice with Diazepam (1 mg/kg, i.p.) sig-
nificantly increased the time spent in open arms in both
LV-shRNA and control mice but not in tPA overexpression mice
[F(2,34)=0.200; pN0.05, n=9–11]. An overall analysis of the
data with a two-way ANOVA indicated a significant effect in-
teraction virus× treatment [F(2,67)=4.143; pb0.05].
3.4. Elevated depression-like behaviors
in tPA-deficient mice
The novelty suppressed feeding (NSF), the tail-suspension test
(TST) and the forced-swimming test (FST) were employed in this
study to investigate the tendency towards depression-like be-
havior in the hippocampal tPA knock down mice groups. We,
therefore, quantified the behavioral-despair with one more
standard paradigm: the novelty suppressed feeding test (NSF).
In this paradigm, tPA manipulation in the hippocampus impairs
the time to feed in mice [F(2,31)=12.505; pb0.05, n=9–11]
(Fig. 4A). Post-hoc evaluation has revealed that LV-shRNA signif-
icantly increases the time to approach the food (pb0.05) where-
as LV-tPA overexpression has the opposite effect compared to
the Mock-injected mice (pb0.01). When lentiviral vectors were
injected in the striatum, the time to feed was not affected [F
(2,31)=0.249; pN0.05] (Fig. 4A). The impaired response of LV-
shRNA mice in the NSF test suggested that they had an increase
in depression levels. We also measured the total amount of food
consumed in the 3 groups but no statistical difference was found
(data not shown). In the tail-suspension test, as shown in
Fig. 4B, tPA manipulation in the hippocampus influenced immo-
bility time in mice [F(2,33)=11.245; pb0.05]. Thus when tPA
expression was blocked in the hippocampus using LV-shRNA, im-
mobility time for mice was significantly higher than that of mock
control animals (pb0.05). In contrast, overexpressing tPA level in
the samebrain region reduced immobility time compared to control
(pb0.05). However, when lentiviral vectors were injected into the
striatum, there was no difference in immobility time of mice be-
tween LV-shRNA, LV-tPA and mock groups [F(2,33)=0.095;
pN0.05]. This phenomenon was also observed in the forced-swim
test [F(2,31)=17.726; pb0.05] (Fig. 4C), which showed significant
increased immobility time in LV-shRNA mice compared to controls
(pb0.01). In contrast, tPA overexpression in the hippocampus re-
duced immobility time in mice compared to Mock-injected mice
(pb0.01). Treatment of mice with the tricyclic uptake inhibitor
imipramine significantly reduced immobility time in both LV-
shRNA and control mice but not in tPA overexpression mice [F
(2,34)=1.620; pN0.05] (Fig. 4C). An overall analysis of the data
Figure 2 Lentiviral-mediated locomotor activity behavior of
mice. A) The total distance during 90 min in mice injected
with viral vectors either in the hippocampus or in the striatum.
B) The total distance in 30 min blocks times from mice injected
with viral vectors in the hippocampus only. There were no sig-
nificant differences between the three groups. *pb0.05 and
**pb0.01 compared to 0–30 min. In both panels, data represent
the mean±SEM. n=9–11 mice per group. Mock: Empty vector,
LV-shRNA: shRNA expressing- and, LV-tPA: tPA expressing-
lentiviral vectors.
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with a two-way ANOVA indicated a significant effect interaction vir-
us×treatment [F(2,65)=9.111; pb0.05]. These results demon-
strate that targeted viral expression of tPA in the hippocampus of
non-stressed mice produces profound depressive-like responses
similar to the effect of forced-swim induced stress.
3.5. tPA enzymatic activity and BDNF protein
expression
The spatial distribution of tPA gene transfer after injection via
the stereotaxic injection described in Experimental procedures
has been previously published (Bahi and Dreyer, 2008; Bahi et
al., 2008b). 60 min after completion of the last behavioral exper-
iment (FST), we quantified tPA enzymatic activity in the hippo-
campus. Results revealed that when mice were injected with
LV-shRNA, tPA activity was reduced approximately 50% [F
(2,16)=12.613; pb0.05, n=5–7] (Fig. 5A). In contrast, LV-tPA in-
creased activity levels in the hippocampus by approx. 60 to 70%
from baseline. Overall, these results indicate that anxiety- and
depression-like behavioral changes depend on tPA activity in the
hippocampus. More importantly, ELISA evaluation revealed that
BDNF protein was reduced approximately 30% after treatment
with AAV-shRNA (Fig. 5B) and increased by approx. 40 to 50% from
baseline when mice were injected with LV-tPA [F(2,17)=11.032;
pb0.05]. Thus, lentiviral-mediated brain delivery of tPA is effec-
tive at increasing its mRNA and enzymatic activity in the adult
mouse hippocampus and consequently increased BDNF protein in
the same brain region.
4. Discussion
In this study we examined the effects of tissue plasminogen
activator “tPA” manipulation in the hippocampus in
depression- and anxiety-like behaviors in mice. The main
findings of the present study were: first, hippocampus tPA,
but not uPA, activity was decreased after forced swim stress.
Second, lentiviral tPA over-expression in the hippocampus
shows robust antidepressant and anxiolytic-like effect. In con-
trast, blocking tPA expression using shRNA-expressing lentiviral
vectors shows depressant and anxiogenic-like effect. Finally,
tPA over-expression protective effect was associated to higher
levels of BDNF proteins in the hippocampus. Taken together,
these findings demonstrate that tPA plays an important role
Figure 3 Effect of tPA manipulation in the hippocampus on anxiety like-behavior in mice. A) The number of buried marbles and, B)
the digging time in marbles burying test. C) The percentage of time in open arms (OA) and, D) the percentage of entries in the OA and,
E) the number of entries in closed arms (CA) of an elevated plus maze (EPM). F) The percentage of entries in OA of the EPM following
diazepam administration. *pb0.05 compared to “Mock”; #pb0.05 compared to “Vehicle”. In all panels, data represent the mean±
SEM. n=9–11 mice per group.
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in psychiatric disorders most probably trough a BDNF
mechanism.
The extracellular serine protease tPA was found to be
highly expressed in mood disorders-associated brain nuclei
including the hippocampus, amygdala, prefrontal cortex
and infra-limbic regions (Lohman et al., 2008; Wu et al.,
2000; Zhou et al., 2010). In the first experiment we found
a decrease of tPA enzymatic activity in the hippocampus of
mice from the stress group when compared to mice from
the control group. More importantly, this effect was
tPA-specific as uPA, a different serine protease, was not af-
fected after stress in mice. Changes in stress-induced tPA
expression and activity were reported both in vitro and in
vivo. In fact, it has been shown that tPA mRNA levels were
higher in primary cultures endothelial cells subjected to
shear stress or cyclic strain than in controls (Diamond et
al., 1990; Iba and Sumpio, 1992; Nollert et al., 1991). This
effect was generalized to several cell lines (Sjogren et al.,
2000; Ueba et al., 1997; Yang et al., 2006). In addition, the
signaling cascade involved in stress-induced tPA expression
is most probably PKC-independent (Levin et al., 1993)
suggesting that environmental stressors may regulate tPA
gene expression. More interestingly, tPA expression changes
were found in humans. In fact, when assessing the effects of
acute laboratory stressors on tPA in a sample of cardiac pa-
tients, participants subjected to mental stress condition
revealed a statistically significant decrease in tPA levels in
blood samples (Hevey et al., 2000). In addition, a significant
decrease of plasma tPA concentration was observed in pa-
tients with depression (Pietraszek et al., 1991). Interestingly,
tPA expression was enhanced in the amygdala following acute
restraint stress (Pawlak et al., 2003). Thus, we can hypothesize
that the enhanced ability of stress to induce tPA enzymatic ac-
tivity in the hippocampusmay affect stress-relatedmood disor-
ders like anxiety and depression.
To further investigate the physiological significance of
stress-induced decrease in tPA enzymatic activity in the hip-
pocampus, we explored the effect of tPA manipulation on
anxiety- and depression-like behaviors in mice. To this end,
we over-express tPA or knock-down its mRNA expression by
mean of shRNA-expressing lentiviral vectors. These tools
have been successfully used to investigate gene function in
the central nervous system (Bahi et al., 2004a, 2006,
2008b, 2008c; Bahi and Dreyer, 2008, 2011). Using marble
burying and elevated plus maze tests we found that
anxiety-like behavior was reduced in tPA over-expressing
mice but significantly exacerbated when tPA transcripts
were inhibited bymean of specific shRNA-expressing lentiviral
vectors in the hippocampus. More importantly, these effects
were region specific as tPAmanipulation in the dorsal striatum
had no effect. These findings are not in the line with previous-
ly published studies in which tPA deficient mice did not show
restraint-induced anxiety (Bennur et al., 2007; Matys et al.,
2004; Pawlak et al., 2003). These findings seem to be in con-
trast to our current observations, but it is likely that the lack
of stress-induced anxiety in tPA knockout mice involves
Figure 4 Effect of tPA manipulation in the hippocampus on
depression like-behavior inmice. A) The time to feed in the novelty
suppressed feeding. B) The immobility time in the tail suspension
test following Imipramin administration. C) The immobility time in
the forced swim test. *pb0.05 compared to “Mock”; #pb0.05 com-
pared to “Vehicle”, . In all panels, data represent the mean±SEM.
n=9–11 mice per group.
Figure 5 Effect of tPA manipulation in the hippocampus on
tPA enzymatic activity and BDNF protein expression. A) The
tPA activity. B) The BDNF protein levels in mice hippocampal
extracts following the last forced swim test.*pb0.05 compared to
“Mock”. In both panels, data represent the mean±SEM. n=5–7
mice per group.
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unknown compensatory mechanisms characterizing conven-
tional gene knockout. Also, developmental neuronal alter-
ations may explain the apparent conflicting results. In fact,
these same KO mice displayed attenuated neuronal remodel-
ing, impaired hormonal response and attenuated stress-
induced spine retraction in the medial amygdala (Bennur et
al., 2007; Matys et al., 2004) which makes it difficult to com-
pare those results with our findings. In the elevated plus
maze test, no changes in the number of entries onto the closed
arms were found. The finding that this last index did not
change allowed us to discard some effect of tPA manipulation
onmotor activity. Besides, the time spent on the open arms in-
creased after tPA over-expression. Because this parameter is
poorly influenced by locomotion, it appeared as a clear
index of anxiety, suggesting that tPA exerted an anxiolytic ef-
fect. Indeed, normal exploratory behavior is directed to the
closed arms, and this tendency can be enhanced by anxiogenic
drugs, which increment the natural aversion towards open
arms. In contrast, anxiolytic agents reduce this aversion and
promote exploration (Britton et al., 1991; Fernandez-Guasti
et al., 2005; Rex et al., 1993; Zangrossi et al., 1992). This
was confirmed in the current study as we have shown that
tPA knock-down-induced anxiety-like behavior was reversed
when diazepam was applied before the test. Taken together,
it is likely that the tPA is crucial in regulating anxiety-like be-
havior in mice.
We also investigated whether tPA manipulation is in-
volved in depression-like behavior using novelty suppressed
feeding, tail suspension and forced swim tests. Our findings
suggest that depression-like behavior was enhanced in
shRNA-expressing mice but tPA over-expression leads to an
attenuated response. In fact, latency to feed and immobility
time were significantly enhanced when tPA mRNA was
blocked by means of shRNA expressing viral vectors com-
pared with control mice (Mock vector). In contrast, those pa-
rameters were attenuated when tPA was over-expressed in
the hippocampus. Importantly, higher BDNF levels were
found in tPA over-expressing hippocampal lysates. These
findings suggest that tPA/BDNF complex activity in the hip-
pocampus plays a crucial role in depression-like behavior in
mice.
A possible role of tPA in Major depressive disorders was
reviewed (Hou et al., 2009; Tsai, 2006, 2007a,b). More inter-
estingly, when plasma BDNF and tPA were measured in late-
onset geriatric depression (LGD) before treatment, it has
been found that, compared to controls, these levels were
significantly lower in LGD patients (Shi et al., 2010). In addi-
tion, BDNF immune-reactivity was higher after antidepres-
sant treatment. Also, post-stroke depression (PSD) patients
displayed significantly lower plasma BDNF than non-PSD pa-
tients (Yang et al., 2011). Very recently, it has been reported
that voluntary physical activity induced a robust increase in
hippocampal BDNF levels, as well as in tPA mRNA expression;
these changes were associated to anti-depressive effects as
compared with sedentary mice (Sartori et al., 2011). In addi-
tion, it has been shown that the BDNF receptor TrkB,modulate
fear learning and amygdala synaptic plasticity through two
main phosphorylation docking sites [Y515/Shc and Y816/
PLCγ] (Musumeci et al., 2009). Taken together, the anti-
depressive effect of tPA over-expression may depend, at
least in part, on changes in BDNF post-translational modifica-
tion. In fact, it is well established that Pro-BDNF cleavage
depends on tPA activity (Barnes and Thomas, 2008; Pang et
al., 2004). Although the cellular and molecular mechanisms
remain to be further clarified, it is suggested that the effects
of tPA might be due to BDNF processing changes in stress-
induced depression- and anxiety-like behaviors.
It is possible that mood regulation involves the tPA/BDNF
system also in other brain areas. tPA is also expressed in the
amygdala and infra-limbic regions, which may participate in
the regulation of stress-related psychiatric illness. In any
case, our data show that tPA plays an important role in mood
regulation, thus providing a potential molecular link between
extracellular proteases and mood regulation. Targeting the
tPA/BDNF system may be a new avenue for the treatment of
mood disorders.
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